146 related articles for article (PubMed ID: 17384145)
1. EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways.
Donnini S; Finetti F; Solito R; Terzuoli E; Sacchetti A; Morbidelli L; Patrignani P; Ziche M
FASEB J; 2007 Aug; 21(10):2418-30. PubMed ID: 17384145
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling.
Hsiao HY; Mak OT; Yang CS; Liu YP; Fang KM; Tzeng SF
Glia; 2007 Jan; 55(2):214-23. PubMed ID: 17091492
[TBL] [Abstract][Full Text] [Related]
4. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR
Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880
[TBL] [Abstract][Full Text] [Related]
6. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma.
Yu L; Wu WK; Li ZJ; Wong HP; Tai EK; Li HT; Wu YC; Cho CH
J Pharmacol Exp Ther; 2008 Oct; 327(1):258-67. PubMed ID: 18583546
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
Gschwind A; Prenzel N; Ullrich A
Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
[TBL] [Abstract][Full Text] [Related]
8. Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways.
Sales KJ; Maudsley S; Jabbour HN
Mol Endocrinol; 2004 Jun; 18(6):1533-45. PubMed ID: 15044590
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway.
Gu D; Li H; Wang Z; Chen Q; Jiang J; Zhu H
Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498
[TBL] [Abstract][Full Text] [Related]
10. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
11. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
12. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.
Lui VW; Thomas SM; Zhang Q; Wentzel AL; Siegfried JM; Li JY; Grandis JR
Oncogene; 2003 Sep; 22(40):6183-93. PubMed ID: 13679857
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
[TBL] [Abstract][Full Text] [Related]
14. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation.
Yano S; Macleod RJ; Chattopadhyay N; Tfelt-Hansen J; Kifor O; Butters RR; Brown EM
Bone; 2004 Sep; 35(3):664-72. PubMed ID: 15336602
[TBL] [Abstract][Full Text] [Related]
15. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
[TBL] [Abstract][Full Text] [Related]
16. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
Wang CY; Wang YT; Tzeng DW; Yang JL
Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
[TBL] [Abstract][Full Text] [Related]
17. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
18. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
[TBL] [Abstract][Full Text] [Related]
19. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
20. The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells.
Suh SJ; Chung TW; Son MJ; Kim SH; Moon TC; Son KH; Kim HP; Chang HW; Kim CH
Arch Biochem Biophys; 2006 Mar; 447(2):136-46. PubMed ID: 16527246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
